US Contrast Media Injectors Market Analysis and Outlook To 2027: Centers of Disease Control & Prevention, Food and Drug Administration, World Health Organization

Press Release

The US Contrast Media Injectors market is expected to reach US$ 350.4 Mn in 2027 from US$ 183.8 Mn in 2018. The market is estimated to grow with a CAGR of 7.5% from 2019-2027.

The growth of the contrast media injectors market is primarily attributed to the increasing number of patients suffering with chronic diseases. However, side effects associated with the contrast media agents is likely to hinder the growth of the market during the forecast period. Additionally, the growth of the US contrast media injectors market is contributed by other factors such as increasing number of approvals for contrast agents as well as robust pipeline products. US has a marginal number of companies headquartered and operating in the contrast media injectors market. The major manufacturing companies through their diversified portfolio that commercializes imaging agents and products also work evidently on the development of new agents and injector systems that are likely to enhance the efficiency of current imaging modalities, thereby bringing in new technologies and innovations in the market that would be responsible to keep the dominance of the country at a US scenario.

Request a Sample Copy of the Research Reporthttps://www.theinsightpartners.com/sample/TIPRE00003911/

Some of the major primary and secondary sources for Contrast Media Injectors included in the report are Centers of Disease Control & Prevention, Food and Drug Administration, World Health Organization and Others.

For instance, Lantheus Medical Imaging, Inc., a US based medical imaging company actively involved in the commercialization of contrast media injectors and agents is undergoing clinical trials to develop Flurpiridaz F 18, a novel PET agent, with the first of two Phase 3 trials complete. Moreover, the company has also collaborated with academic centers in the U.S., Canada and the Europe to investigate fluorine-18-based positron emission tomography (PET) radiopharmaceutical imaging agent designed for molecular imaging of the norepinephrine pathway. Thus, similar potential products that are beneficial from the commercial as well as therapeutic and diagnostic perspectives is expected to create opportunistic scenario for the growth of the contrast media injectors market in the coming years.

Avail discount on this report @ https://www.theinsightpartners.com/discount/TIPRE00003911/

Additionally, there presence of robust products in the pipeline have been witnessed in the contrast media injectors market. For instance, Lantheus Medical Imaging, Inc., a US based medical imaging company actively involved in the commercialization of contrast media injectors and agents is undergoing clinical trials to develop Flurpiridaz F 18, a novel PET agent, with the first of two Phase 3 trials complete. Moreover, the company has also collaborated with academic centers in the U.S., Canada and the Europe to investigate fluorine-18-based positron emission tomography (PET) radiopharmaceutical imaging agent designed for molecular imaging of the norepinephrine pathway.

In 2018, the consumables segment held a largest market share of 63.0% of the contrast media injectors market, by product. This segment is also expected to dominate the market in 2027 since the consumables generally used are meant for single use and hence are replaced after the completion of every process. Moreover, the consumables segment is anticipated to witness the significant growth rate of 7.7% during the forecast period, 2019 to 2027.

US Contrast Media Injectors market by application was led by the radiology segment. The segment has largest market share in 2018, which accounted 47.3% and is expected to dominate the market in 2027. However, the interventional cardiology segment is expected to witness growth at a significant rate of 8.5% during the forecast period, 2019 to 2027.

Purchase this Report @ https://www.theinsightpartners.com/buy/TIPRE00003911/

Major Highlights Of The Report:

All-inclusive evaluation of the parent market

Evolution of significant market aspects

Industry-wide investigation of market segments

Assessment of market value and volume in past, present, and forecast years

Evaluation of market share

Study of niche industrial sectors

Tactical approaches of market leaders

Lucrative strategies to help companies strengthen their position in the market

US CONTRAST MEDIA INJECTORS– MARKET SEGMENTATION

By Product

  • Injector Systems
    • MRI Injector Systems
    • CT Injector Systems
    • Angiography Injector Systems
  • Consumables
    • Injector Heads
      • Single Head Injectors
      • Dual Head Injectors
      • Syringe less Injectors
    • Tubing
    • Syringes
    • Other Consumables
  • Accessories

US CONTRAST MEDIA INJECTORS – MARKET SEGMENTATION

By Application

  • Interventional Cardiology
  • Interventional Radiology
  • Radiology

Contact Us:

Call: +1-646-491-9876

Email: [email protected]

Related posts